Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3862211 | The Journal of Urology | 2012 | 5 Pages |
Abstract
The magnitude of change in serum prostate specific antigen after 5α-reductase inhibitor therapy may be useful in diagnosing prostate cancer in patients with persistently increased or fluctuating prostate specific antigen and prior negative prostate biopsy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Steven A. Kaplan, Richard K. Lee, Doreen E. Chung, Alexis E. Te, Douglas S. Scherr, Ash Tewari, E. Darracott Vaughan,